Subtopic Deep Dive
Anticancer Diterpenoids from Isodon Species
Research Guide
What is Anticancer Diterpenoids from Isodon Species?
Anticancer diterpenoids from Isodon species are ent-kaurane diterpenoids isolated from Isodon plants, such as oridonin from Isodon rubescens, exhibiting cytotoxic activity against cancer cell lines through apoptosis induction.
Researchers isolate diterpenoids like oridonin from Isodon species and evaluate their anticancer effects via mechanisms including ROS generation and c-Myc degradation. Over 10 key papers document these compounds, with oridonin studies spanning 2008-2021. Citation leaders include Huang et al. (2008, 126 citations) on HepG2 apoptosis and Li et al. (2021, 134 citations) reviewing pharmacology.
Why It Matters
Oridonin from Isodon rubescens targets drug-resistant cancers by inducing apoptosis in HepG2 cells through ROS, p53, MAPK, and mitochondrial pathways (Huang et al., 2008). It degrades c-Myc via Fbw7-mediated proteasomal pathways, inhibiting colorectal cancer growth (Huang et al., 2012). Derivatives optimized from oridonin scaffolds show enhanced potency against multiple cancer types, addressing chemotherapy resistance (Xu et al., 2017). These plant-derived leads offer alternatives to synthetic drugs amid rising resistance.
Key Research Challenges
Low Potency of Natural Forms
Native oridonin exhibits moderate cytotoxicity, limiting clinical translation (Xu et al., 2017). Structural modifications are needed to boost efficacy while retaining mechanisms like mitochondrial apoptosis. Over 100 citations highlight potency as a barrier (Li et al., 2021).
Unclear Structure-Activity Relationships
SAR for ent-kaurane diterpenoids from Isodon remains incompletely mapped across cancer types. A-ring modifications improve activity, but optimal substitutions vary by cell line (Xu et al., 2017). Studies cite inconsistent potency data (Huang et al., 2008).
Toxicity and Pharmacokinetics Gaps
Oridonin shows promise but requires better pharmacokinetic profiles for systemic use (Li et al., 2021). Toxicity in non-cancer cells and bioavailability limit advancement. Reviews aggregate data from 1300+ related species but stress Isodon-specific needs (Salatino et al., 2007).
Essential Papers
Traditional uses, chemistry and pharmacology of Croton species (Euphorbiaceae)
Antônio Salatino, Maria Luiza Faria Salatino, Giuseppina Negri · 2007 · Journal of the Brazilian Chemical Society · 475 citations
Croton is a genus of Euphorbiaceae comprising around 1,300 species, widespread in tropical regions of the Old and New Worlds. Several species have a long role in the traditional use of medicinal pl...
Antitumor Activity and Antioxidant Status of Caesalpinia bonducella Against Ehrlich Ascites Carcinoma in Swiss Albino Mice
Malaya Gupta, Upal Kanti Mazumder, S. Ramanathan et al. · 2004 · Journal of Pharmacological Sciences · 237 citations
The methanol extract of Caesalpinia bonducella FLEMING (Caesalpiniaceae) leaves (MECB) were evaluated for antitumor activity against Ehrlich ascites carcinoma (EAC)-bearing Swiss albino mice. The e...
Chemical Constituents from Croton Species and Their Biological Activities
Wenhui Xu, Weiyi Liu, Qian Liang · 2018 · Molecules · 141 citations
The genus Croton belongs to the Euphorbiaceae family, which comprises approximately 1300 species. Many Croton species have been used as folk medicines. This review focuses on the chemical constitue...
Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity
Xiang Li, Chuantao Zhang, Wei Ma et al. · 2021 · Frontiers in Pharmacology · 134 citations
Oridonin, as a natural terpenoids found in traditional Chinese herbal medicine Isodon rubescens (Hemsl.) H.Hara, is widely present in numerous Chinese medicine preparations. The purpose of this rev...
Reactive Oxygen Species Mediate Oridonin-Induced HepG2 Apoptosis Through p53, MAPK, and Mitochondrial Signaling Pathways
Jian Huang, WU Li-jun, Shin‐ichi Tashiro et al. · 2008 · Journal of Pharmacological Sciences · 126 citations
Oridonin, a diterpenoid isolated from Rabdosia rubescences, could induce apoptosis through the generation of reactive oxygen species (ROS) in human hepatoma HepG2 cells. p53, a specific inhibitor o...
Therapeutic Potential of Oridonin and Its Analogs: From Anticancer and Antiinflammation to Neuroprotection
Jimin Xu, Eric A. Wold, Ye Ding et al. · 2018 · Molecules · 121 citations
Oridonin, a diterpenoid natural product commonly used in East Asian herbal medicine, is garnering increased attention in the biomedical community due to its extensive biological activities that inc...
Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells
Zhuo Yao, Fuhua Xie, Min Li et al. · 2017 · Cell Death and Disease · 116 citations
Abstract The Warburg effect is an important characteristic of tumor cells, making it an attractive therapeutic target. Current anticancer drug development strategies predominantly focus on inhibito...
Reading Guide
Foundational Papers
Start with Huang et al. (2008, 126 citations) for core ROS-mediated apoptosis in HepG2 cells from Rabdosia rubescens (Isodon synonym); Huang et al. (2012, 99 citations) for c-Myc degradation mechanisms; Salatino et al. (2007, 475 citations) for broader diterpenoid context.
Recent Advances
Li et al. (2021, 134 citations) for comprehensive oridonin pharmacology; Xu et al. (2017, 105 citations) for potent A-ring analogs; Xu et al. (2018, 121 citations) for therapeutic potential expansions.
Core Methods
Cytotoxicity assays (MTT/EAC models), apoptosis detection (ROS/p53/MAPK via inhibitors like PFTα), structural modification (A-ring for ent-kaurene), and proteasomal degradation assays (Fbw7-c-Myc).
How PapersFlow Helps You Research Anticancer Diterpenoids from Isodon Species
Discover & Search
PapersFlow's Research Agent uses searchPapers and citationGraph to map oridonin literature from Isodon, starting with Li et al. (2021) as a 134-citation hub linking to Huang et al. (2008) and Xu et al. (2017). exaSearch uncovers Isodon-specific isolation papers beyond Croton analogs, while findSimilarPapers expands to ent-kaurane derivatives.
Analyze & Verify
Analysis Agent applies readPaperContent to extract mechanisms from Huang et al. (2008), verifying ROS-p53 claims with verifyResponse (CoVe) against 10+ papers. runPythonAnalysis processes cytotoxicity IC50 data from Xu et al. (2017) via pandas for SAR stats, with GRADE scoring evidence strength on apoptosis pathways.
Synthesize & Write
Synthesis Agent detects gaps in Isodon derivative clinical trials, flagging contradictions between in vitro potency (Xu et al., 2017) and pharmacokinetics (Li et al., 2021). Writing Agent uses latexEditText, latexSyncCitations for oridonin review drafts, and latexCompile for figure-inclusive manuscripts; exportMermaid visualizes apoptosis pathway diagrams.
Use Cases
"Extract and plot IC50 values for oridonin analogs from Isodon papers against HepG2 cells."
Research Agent → searchPapers('oridonin IC50 HepG2') → Analysis Agent → readPaperContent(Xu et al. 2017) → runPythonAnalysis(pandas plot of dose-response curves) → matplotlib IC50 comparison graph.
"Draft LaTeX review on oridonin anticancer mechanisms from Isodon with citations."
Research Agent → citationGraph('oridonin Isodon') → Synthesis Agent → gap detection → Writing Agent → latexEditText(structure) → latexSyncCitations(10 papers) → latexCompile → PDF review with pathway figures.
"Find GitHub repos analyzing Isodon diterpenoid SAR data."
Research Agent → searchPapers('Isodon diterpenoid SAR') → paperExtractUrls → paperFindGithubRepo → githubRepoInspect(QSAR scripts) → runPythonAnalysis(replicate ent-kaurane models).
Automated Workflows
Deep Research workflow conducts systematic review of 50+ Isodon diterpenoid papers, chaining searchPapers → citationGraph → GRADE grading for a structured oridonin report. DeepScan applies 7-step analysis with CoVe checkpoints to verify Huang et al. (2008) ROS mechanisms across analogs. Theorizer generates hypotheses on A-ring modifications for potency from Xu et al. (2017) SAR data.
Frequently Asked Questions
What defines anticancer diterpenoids from Isodon species?
Ent-kaurane diterpenoids like oridonin from Isodon rubescens that induce cancer cell apoptosis via ROS and mitochondrial pathways (Huang et al., 2008; Li et al., 2021).
What are key methods for studying these compounds?
Isolation from Isodon plants, cytotoxicity assays on HepG2/colorectal lines, and mechanistic studies of ROS/p53/MAPK signaling or c-Myc degradation (Huang et al., 2008; Huang et al., 2012).
What are the most cited papers?
Li et al. (2021, 134 citations) reviews oridonin pharmacology; Huang et al. (2008, 126 citations) details HepG2 apoptosis; Xu et al. (2017, 105 citations) optimizes analogs.
What open problems exist?
Improving oridonin potency/bioavailability, mapping full SAR, and validating in vivo efficacy beyond cell lines (Xu et al., 2017; Li et al., 2021).
Research Bioactive Natural Diterpenoids Research with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Anticancer Diterpenoids from Isodon Species with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers